The natural course of acute myeloid leukemia without treatment is about 3-6 months, and with aggressive chemotherapy, 50% of patients can survive for 3-5 years. The survival time of patients is influenced by a variety of factors such as their own factors (age, physical status, whether they have other comorbid diseases), and disease-related factors (mainly MICM staging), and with aggressive chemotherapy, 50% of patients can survive 3-5 years. For example, acute promyelocytic leukemia, also known as type m3, can be treated with retinoic acid and arsenic, and the clinical cure rate can reach more than 95%. Patients with acute myeloid leukemia should actively cooperate with the doctor for treatment, establish confidence and maintain an optimistic attitude can improve the prognosis. At the same time, avoid spicy and stimulating food in the diet and avoid bumping in daily life to prevent bleeding and other phenomena.